https://archive.md/u95h7
"Rachael Sirianni first learned her lab might be in trouble just a few weeks
into the new year. A professor at the University of Massachusetts Chan Medical
School, in Worcester, Sirianni focuses primarily on an aggressive form of
pediatric brain cancer known as medulloblastoma. Researchers have made great
strides in treating these tumors, but they are still often fatal, and even
successful treatments can come with devastating side effects. Sirianni had
spent the last several years working on a potentially transformative approach
to treating the most malignant type of medulloblastoma and was making real
progress.
Pediatric brain cancer research is expensive. UMass Chan pays for some of
Sirianni’s work, but most of her funding comes from the federal government.
Entering 2025, she had three active grants at the National Institutes of Health
that were all set to expire either this year or in 2026. She was prepared. In
2024, she submitted two new applications to continue her research. Both
proposals had cleared the first hurdle at the N.I.H., earning strong scores
from a panel of independent experts in the field. They were scheduled for
another review at the agency in late January.
But then, in the days after Trump’s inauguration, Sirianni started hearing
rumors that he was planning to disrupt the N.I.H.’s grant-making process. As it
turned out, he did much more than that. In late January, his administration
ordered the N.I.H. to cancel meetings to consider pending grant applications."
Original at
<
https://www.nytimes.com/2025/09/14/magazine/cancer-research-grants-funds-trump.html>
Via Susan ****
Cheers,
*** Xanni ***
--
mailto:xanni@xanadu.net Andrew Pam
http://xanadu.com.au/ Chief Scientist, Xanadu
https://glasswings.com.au/ Partner, Glass Wings
https://sericyb.com.au/ Manager, Serious Cybernetics
